Dermavest® is a skin replacement derived from particularized, decellularized human placental tissue extracellular matrix.
• Five times the connective tissue of amnion-chorion alone
• Easy to handle
• Swells to flow over the wound and cover more area
• Complete contact with wound eliminates separation from bed
Dermavest® is indicated for use on diabetic ulcers, pressure ulcers, burns, venous ulcers, and post-Mohs surgery.
Contraindicated for use on individuals with a known sensitivity to the product or its components.
Store at room temperature. Three year shelf life.
Human placental connective tissue matrix
|Assigned HCPCS code||●|
|Shelf life greater than 2 years||●|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
Carefully place Dermavest® onto the area of application. Tear pieces as needed.
Change as needed.
Cover with a non-adherent dressing.
Aedicell is a regenerative medicine company that has developed a unique proprietary process to transform human tissue into a biologic for therapy.